Bioabsorbable Stents Market by Biomaterial (Polymeric Stents and Metallic Stents), Application (Coronary Artery Disease and Peripheral Artery Disease), and End User (Hospital and Cardiac Centers): Global Opportunity Analysis and Industry Forecast, 2020–2027
The global bioabsorbable stents market was valued at $283.60 million in 2019, and is projected to reach $308.90 million by 2027, registering a CAGR of 5.6% from 2020 to 2027.A stent is a medical device which is inserted into the internal duct of the body for expanding the blood vessels and preventing the vessels from blockage. Bioabsorbable stents, also known as bioresorbable stents or naturally-dissolving stents, are made up of materials that get absorbed in the body and act by expanding the vessels or internal duct for clearing the blockage caused due to the deposition of plague. These devices are designed in such a way that after eluting the drug, the stents gets dissolved within the body at certain interval of time.
Growth of the global bioabsorbable stents market is majorly driven by increase in prevalence of heart diseases, rise in geriatric population, surge in percutaneous coronary intervention (PCI) procedure, rise in adaptation of bioabsorbable stent by patients and physician, advancement in technology in stents, and growth in demand for minimally invasive procedures. For instance, according to the Centers for Disease Control and Prevention (CDC), the global wide prevalence of coronary heart diseases in 2017 was around 18.2 million individuals and approximately 2 in 10 people died due to coronary heart disease. Moreover, Arterius Limited, in April 2019, collaborated with Translational Biomedical Research Centre for the development of new bioabsorbable stents to get accurate and reliable results. As per data published by the European Cardiovascular Disease, it was reported that each year, 3.9 million people die due to cardiovascular diseases in Europe and 1.8 million deaths occurred in the European Union. Hence, increase in incidences of heart disease (mostly coronary and peripheral heart disease) is expected to propel the demand for bioabsorbable stents, which, in turn, fosters the market growth. In addition, the unhealthy diet habits and lack of physical activities are gaining traction across the globe, owing to rise in prevalence or cardiovascular diseases and availability of percutaneous coronary intervention (PCI) procedure. For instance, in April 2021, the MicroPort Scientific Corporation launched Castor Branched Stent-Graft system, which has its application for the treatment of aortic arch repair by minimally invasive surgical procedure. As per the latest data by interventional cardiology procedural analysis, in 2020, it was found that around 965,000 angioplasties procedure was performed each year in the U.S.. Further, in March 2021, Elixir Medical Corporation, a developer of drug-eluting cardiovascular devices, announced the result of the INFINITY SWEDEHEART randomized controlled trial (RCT) of DynamX Coronary Bioadaptor system. The result states that dynamx Coronary bioadaptor has no target of myocardial infarction or thrombosis through 24 months. Rise in demand for minimally invasive surgical procedure, advancement in technology for innovation of novel bioabsorbable stents and increase in adoption of percutaneous coronary intervention procedure drive the growth of the global market.
Moreover, high costs of stents procedure and risk associated with the use of bioabsorbable stents are anticipated to restrain the market growth during the forecast period. In some cases, due to high risk many players are forced to withdraw their devices from the market, which in turn decreases their revenue for bioabsorbable stents. For instance, in 2017, Abbott and Boston Scientific has withdrawn their products due to high risk factors. Researchers are still working on the drawback of Absorb which develops myocardial infraction and thick strut and aim to develop a novel bioabsorbable stent by overcoming the risk associated with it. Thus, growth in adoption of new technology and rise in activities of R&D in healthcare sector are expected to provide an opportunity for the bioabsorbable stents market growth.
The bioabsorbable stents market is segmented on the basis of biomaterial, application, end user, and region. On the basis of biomaterial, the market is divided into polymeric stents and metallic stents. On the basis of application, the market is bifurcated into coronary artery disease and peripheral artery disease. On the basis of end user, the market is classified into hospital and cardiac centers. On the basis of region, the bioabsorbable stents market is analysed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
By Biomaterial
Growth of the global bioabsorbable stents market is majorly driven by increase in prevalence of heart diseases, rise in geriatric population, surge in percutaneous coronary intervention (PCI) procedure, rise in adaptation of bioabsorbable stent by patients and physician, advancement in technology in stents, and growth in demand for minimally invasive procedures. For instance, according to the Centers for Disease Control and Prevention (CDC), the global wide prevalence of coronary heart diseases in 2017 was around 18.2 million individuals and approximately 2 in 10 people died due to coronary heart disease. Moreover, Arterius Limited, in April 2019, collaborated with Translational Biomedical Research Centre for the development of new bioabsorbable stents to get accurate and reliable results. As per data published by the European Cardiovascular Disease, it was reported that each year, 3.9 million people die due to cardiovascular diseases in Europe and 1.8 million deaths occurred in the European Union. Hence, increase in incidences of heart disease (mostly coronary and peripheral heart disease) is expected to propel the demand for bioabsorbable stents, which, in turn, fosters the market growth. In addition, the unhealthy diet habits and lack of physical activities are gaining traction across the globe, owing to rise in prevalence or cardiovascular diseases and availability of percutaneous coronary intervention (PCI) procedure. For instance, in April 2021, the MicroPort Scientific Corporation launched Castor Branched Stent-Graft system, which has its application for the treatment of aortic arch repair by minimally invasive surgical procedure. As per the latest data by interventional cardiology procedural analysis, in 2020, it was found that around 965,000 angioplasties procedure was performed each year in the U.S.. Further, in March 2021, Elixir Medical Corporation, a developer of drug-eluting cardiovascular devices, announced the result of the INFINITY SWEDEHEART randomized controlled trial (RCT) of DynamX Coronary Bioadaptor system. The result states that dynamx Coronary bioadaptor has no target of myocardial infarction or thrombosis through 24 months. Rise in demand for minimally invasive surgical procedure, advancement in technology for innovation of novel bioabsorbable stents and increase in adoption of percutaneous coronary intervention procedure drive the growth of the global market.
Moreover, high costs of stents procedure and risk associated with the use of bioabsorbable stents are anticipated to restrain the market growth during the forecast period. In some cases, due to high risk many players are forced to withdraw their devices from the market, which in turn decreases their revenue for bioabsorbable stents. For instance, in 2017, Abbott and Boston Scientific has withdrawn their products due to high risk factors. Researchers are still working on the drawback of Absorb which develops myocardial infraction and thick strut and aim to develop a novel bioabsorbable stent by overcoming the risk associated with it. Thus, growth in adoption of new technology and rise in activities of R&D in healthcare sector are expected to provide an opportunity for the bioabsorbable stents market growth.
The bioabsorbable stents market is segmented on the basis of biomaterial, application, end user, and region. On the basis of biomaterial, the market is divided into polymeric stents and metallic stents. On the basis of application, the market is bifurcated into coronary artery disease and peripheral artery disease. On the basis of end user, the market is classified into hospital and cardiac centers. On the basis of region, the bioabsorbable stents market is analysed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global bioabsorbable stents market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global bioabsorbable stents market.
By Biomaterial
- Polymeric Stents
- Metallic Stents
- Coronary Artery Disease
- Peripheral Artery Disease
- Hospital
- Cardiac Centers
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Arabia
- South Africa
- Rest of LAMEA
- Arterial Remodeling Technologies
- Arterius Limited
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Elixir Medical Corporation
- Microport Scientific Corporation
- Kyoto Medical Planning Co. Ltd.
- Reva Medical, Inc.
- Terumo Corporation
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of heart diseases and rise in geriatric population
3.5.1.2.Rise in technological advancements in bioabsorbable Stents
3.5.1.3.Increase in demand for the minimally invasive procedure
3.5.1.4.Growth in development of healthcare infrastructure and increases in R&D
3.5.2.Restraints
3.5.2.1.High cost of procedure associated with bioabsorbable stents
3.5.2.2.Risk associated with bioabsorbable stents
3.5.3.Opportunity
3.5.3.1.Increase in R&D and advancement in technology
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the Bioabsorbable Stents market
CHAPTER 4:BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL
4.1.Overview
4.1.1.Market size and forecast
4.2.Polymeric Stents
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Metallic Stents
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
CHAPTER 5:BIOABSORBABLE STENTS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Coronary Artery Disease
5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Peripheral Artery Disease
5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
CHAPTER 6:BIOABSORBABLE STENTS MARKET, BY END USE
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Cardiac Centers
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
CHAPTER 7:BIOABSORBABLE STENTS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America market size and forecast, by biomaterial
7.2.3.North America market size and forecast, by application
7.2.4.North America market size and forecast, by end user
7.2.5.North America market size and forecast, by country
7.2.5.1.U.S. market size and forecast, by biomaterial
7.2.5.2.U.S. market size and forecast, by application
7.2.5.3.U.S. market size and forecast, by end user
7.2.5.4.Canada market size and forecast, by biomaterial
7.2.5.5.Canada market size and forecast, by application
7.2.5.6.Canada market size and forecast, by end user
7.2.5.7.Mexico market size and forecast, by biomaterial
7.2.5.8.Mexico market size and forecast, by application
7.2.5.9.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe market size and forecast, by biomaterial
7.3.3.Europe market size and forecast, by application
7.3.4.Europe market size and forecast, by end user
7.3.5.Europe market size and forecast, by country
7.3.5.1.Germany market size and forecast, by biomaterial
7.3.5.2.Germany market size and forecast, by application
7.3.5.3.Germany market size and forecast, by end user
7.3.5.4.France market size and forecast, by biomaterial
7.3.5.5.France market size and forecast, by application
7.3.5.6.France market size and forecast, by end user
7.3.5.7.UK market size and forecast, by biomaterial
7.3.5.8.UK market size and forecast, by application
7.3.5.9.UK market size and forecast, by end user
7.3.5.10.Italy market size and forecast, by biomaterial
7.3.5.11.Italy market size and forecast, by application
7.3.5.12.Italy market size and forecast, by end user
7.3.5.13.Spain market size and forecast, by biomaterial
7.3.5.14.Spain market size and forecast, by application
7.3.5.15.Spain market size and forecast, by end user
7.3.5.16.Rest of Europe market size and forecast, by biomaterial
7.3.5.17.Rest of Europe market size and forecast, by application
7.3.5.18.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by biomaterial
7.4.3.Asia-Pacific market size and forecast, by application
7.4.4.Asia-Pacific market size and forecast, by end user
7.4.5.Asia-Pacific market size and forecast, by country
7.4.5.1.Japan market size and forecast, by biomaterial
7.4.5.2.Japan market size and forecast, by application
7.4.5.3.Japan market size and forecast, by end user
7.4.5.4.China market size and forecast, by biomaterial
7.4.5.5.China market size and forecast, by application
7.4.5.6.China market size and forecast, by end user
7.4.5.7.India market size and forecast, by biomaterial
7.4.5.8.India market size and forecast, by application
7.4.5.9.India market size and forecast, by end user
7.4.5.10.Rest of Asia-Pacific market size and forecast, by biomaterial
7.4.5.11.Rest of Asia-Pacific market size and forecast, by application
7.4.5.12.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by biomaterial
7.5.3.LAMEA market size and forecast, by application
7.5.4.LAMEA market size and forecast, by end user
7.5.5.LAMEA market size and forecast, by country
7.5.5.1.Brazil market size and forecast, by biomaterial
7.5.5.2.Brazil market size and forecast, by application
7.5.5.3.Brazil market size and forecast, by end user
7.5.5.4.Saudi Arabia market size and forecast, by biomaterial
7.5.5.5.Saudi Arabia market size and forecast, by application
7.5.5.6.Saudi Arabia market size and forecast, by end user
7.5.5.7.South Africa market size and forecast, by biomaterial
7.5.5.8.South Africa market size and forecast, by application
7.5.5.9.South Africa market size and forecast, by end user
7.5.5.10.Rest of LAMEA market size and forecast, by biomaterial
7.5.5.11.Rest of LAMEA market size and forecast, by application
7.5.5.12.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ARTERIAL REMODELING TECHNOLOGIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.2.ARTERIUS LIMITED
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.B. BRAUN MELSUNGEN AG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.BIOTRONIK SE & CO. KG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments
8.5.BOSTON SCIENTIFIC CORPORATION
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.ELIXIR MEDICAL CORPORATION
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.KYOTO MEDICAL PLANNING CO. LTD
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.MICROPORT SCIENTIFIC CORPORATION
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.REVA MEDICAL, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.9.4.Key strategic moves and developments
8.10.TERUMO CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of heart diseases and rise in geriatric population
3.5.1.2.Rise in technological advancements in bioabsorbable Stents
3.5.1.3.Increase in demand for the minimally invasive procedure
3.5.1.4.Growth in development of healthcare infrastructure and increases in R&D
3.5.2.Restraints
3.5.2.1.High cost of procedure associated with bioabsorbable stents
3.5.2.2.Risk associated with bioabsorbable stents
3.5.3.Opportunity
3.5.3.1.Increase in R&D and advancement in technology
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the Bioabsorbable Stents market
CHAPTER 4:BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL
4.1.Overview
4.1.1.Market size and forecast
4.2.Polymeric Stents
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Metallic Stents
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
CHAPTER 5:BIOABSORBABLE STENTS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Coronary Artery Disease
5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Peripheral Artery Disease
5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
CHAPTER 6:BIOABSORBABLE STENTS MARKET, BY END USE
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Cardiac Centers
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
CHAPTER 7:BIOABSORBABLE STENTS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America market size and forecast, by biomaterial
7.2.3.North America market size and forecast, by application
7.2.4.North America market size and forecast, by end user
7.2.5.North America market size and forecast, by country
7.2.5.1.U.S. market size and forecast, by biomaterial
7.2.5.2.U.S. market size and forecast, by application
7.2.5.3.U.S. market size and forecast, by end user
7.2.5.4.Canada market size and forecast, by biomaterial
7.2.5.5.Canada market size and forecast, by application
7.2.5.6.Canada market size and forecast, by end user
7.2.5.7.Mexico market size and forecast, by biomaterial
7.2.5.8.Mexico market size and forecast, by application
7.2.5.9.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe market size and forecast, by biomaterial
7.3.3.Europe market size and forecast, by application
7.3.4.Europe market size and forecast, by end user
7.3.5.Europe market size and forecast, by country
7.3.5.1.Germany market size and forecast, by biomaterial
7.3.5.2.Germany market size and forecast, by application
7.3.5.3.Germany market size and forecast, by end user
7.3.5.4.France market size and forecast, by biomaterial
7.3.5.5.France market size and forecast, by application
7.3.5.6.France market size and forecast, by end user
7.3.5.7.UK market size and forecast, by biomaterial
7.3.5.8.UK market size and forecast, by application
7.3.5.9.UK market size and forecast, by end user
7.3.5.10.Italy market size and forecast, by biomaterial
7.3.5.11.Italy market size and forecast, by application
7.3.5.12.Italy market size and forecast, by end user
7.3.5.13.Spain market size and forecast, by biomaterial
7.3.5.14.Spain market size and forecast, by application
7.3.5.15.Spain market size and forecast, by end user
7.3.5.16.Rest of Europe market size and forecast, by biomaterial
7.3.5.17.Rest of Europe market size and forecast, by application
7.3.5.18.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by biomaterial
7.4.3.Asia-Pacific market size and forecast, by application
7.4.4.Asia-Pacific market size and forecast, by end user
7.4.5.Asia-Pacific market size and forecast, by country
7.4.5.1.Japan market size and forecast, by biomaterial
7.4.5.2.Japan market size and forecast, by application
7.4.5.3.Japan market size and forecast, by end user
7.4.5.4.China market size and forecast, by biomaterial
7.4.5.5.China market size and forecast, by application
7.4.5.6.China market size and forecast, by end user
7.4.5.7.India market size and forecast, by biomaterial
7.4.5.8.India market size and forecast, by application
7.4.5.9.India market size and forecast, by end user
7.4.5.10.Rest of Asia-Pacific market size and forecast, by biomaterial
7.4.5.11.Rest of Asia-Pacific market size and forecast, by application
7.4.5.12.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by biomaterial
7.5.3.LAMEA market size and forecast, by application
7.5.4.LAMEA market size and forecast, by end user
7.5.5.LAMEA market size and forecast, by country
7.5.5.1.Brazil market size and forecast, by biomaterial
7.5.5.2.Brazil market size and forecast, by application
7.5.5.3.Brazil market size and forecast, by end user
7.5.5.4.Saudi Arabia market size and forecast, by biomaterial
7.5.5.5.Saudi Arabia market size and forecast, by application
7.5.5.6.Saudi Arabia market size and forecast, by end user
7.5.5.7.South Africa market size and forecast, by biomaterial
7.5.5.8.South Africa market size and forecast, by application
7.5.5.9.South Africa market size and forecast, by end user
7.5.5.10.Rest of LAMEA market size and forecast, by biomaterial
7.5.5.11.Rest of LAMEA market size and forecast, by application
7.5.5.12.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ARTERIAL REMODELING TECHNOLOGIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.2.ARTERIUS LIMITED
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.B. BRAUN MELSUNGEN AG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.BIOTRONIK SE & CO. KG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments
8.5.BOSTON SCIENTIFIC CORPORATION
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.ELIXIR MEDICAL CORPORATION
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.KYOTO MEDICAL PLANNING CO. LTD
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.MICROPORT SCIENTIFIC CORPORATION
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.REVA MEDICAL, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.9.4.Key strategic moves and developments
8.10.TERUMO CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027 ($MILLION)
TABLE 02.POLYMERIC BIOABSORBABLE STENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.METALLIC BIOABSORBABLE STENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 05.BIOABSORBABLE STENTS MARKET FOR CORONARY ARTERY DISEASE, BY REGION, 2019–2027 ($MILLION)
TABLE 06.BIOABSORBABLE STENTS MARKET FOR PERIPHERAL ARTERY DISEASE, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL BIOABSORBABLE STENTS MARKET, BY END USE, 2019–2027 ($MILLION)
TABLE 08.BIOABSORBABLE STENTS MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.BIOABSORBABLE STENTS MARKET FOR CARDIAC CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 10.BIOABSORBABLE STENTS MARKET, BY REGION, 2019–2027, ($MILLION)
TABLE 11.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 12.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 15.U.S. BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 16.U.S. BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 17.U.S. BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 18.CANADA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 19.CANADA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 20.CANADA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 21.MEXICO BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 22.MEXICO BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 23.MEXICO BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 24.EUROPE BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 25.EUROPE BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 26.EUROPE BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 27.EUROPE BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 28.GERMANY BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 29.GERMANY BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 30.GERMANY BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 31.FRANCE BIOABSORBABLE STENTS MARKET, BY BIOMATERAIL, 2019–2027, ($MILLION)
TABLE 32.FRANCE BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 33.FRANCE BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 34.UK BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 35.UK BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 36.UK BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 37.ITALY BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 38.ITALY BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 39.ITALY BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 40.SPAIN BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 41.SPAIN BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 42.SPAIN BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 43.REST OF EUROPE BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 44.REST OF EUROPE BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 45.REST OF EUROPE BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 46.ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 47.ASIA PACIFIC BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 48.ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 49.ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 50.JAPAN BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 51.JAPAN BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 52.JAPAN BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 53.CHINA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 54.CHINA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 55.CHINA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 56.INDIA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 57.INDIA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 58.INDIA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 59.REST OF ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 60.REST OF ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 61.REST OF ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 62.LAMEA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 63.LAMEA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 64.LAMEA BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 65.LAMEA BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 66.BRAZIL BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 67.BRAZIL BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 68.BRAZIL BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 69.SAUDI ARABIA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 70.SAUDI ARABIA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 71.SAUDI ARABIA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 72.SOUTH AFRICA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 73.SOUTH AFRICA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 74.SOUTH AFRICA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 75.REST OF LAMEA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 76.REST OF LAMEA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 77.REST OF LAMEA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 78.ART: COMPANY SNAPSHOT
TABLE 79.ART: OERATING SEGMENT
TABLE 80.ART: PRODUCT PORTFOLIO
TABLE 81.ARTERIUS: COMPANY SNAPSHOT
TABLE 82.ARTERIUS: OERATING SEGMENT
TABLE 83.ARTERIUS: PRODUCT PORTFOLIO
TABLE 84.B. BRAUN: COMPANY SNAPSHOT
TABLE 85.B. BRAUN: OERATING SEGMENT
TABLE 86.B. BRAUN: PRODUCT PORTFOLIO
TABLE 87.BIOTRONIK: COMPANY SNAPSHOT
TABLE 88.BIOTRONIK: OERATING SEGMENT
TABLE 89.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 90.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 91.BOSTON SCIENTIFIC: OERATING SEGMENT
TABLE 92.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 93.ELIXIR MEDICAL: COMPANY SNAPSHOT
TABLE 94.ELIXIR MEDICAL: OERATING SEGMENT
TABLE 95.ELIXIR MEDICAL: PRODUCT PORTFOLIO
TABLE 96.KYOTO MEDICAL PLANNING: COMPANY SNAPSHOT
TABLE 97.KYOTO MEDICAL PLANNING: OERATING SEGMENT
TABLE 98.KYOTO MEDICAL PLANNING: PRODUCT PORTFOLIO
TABLE 99.MICROPORT: COMPANY SNAPSHOT
TABLE 100.MICROPORT: OERATING SEGMENT
TABLE 101.MICROPORT: PRODUCT PORTFOLIO
TABLE 102.REVA MEDICAL: COMPANY SNAPSHOT
TABLE 103.REVA MEDICAL: PRODUCT PORTFOLIO
TABLE 104.TERUMO: COMPANY SNAPSHOT
TABLE 105.TERUMO: OERATING SEGMENT
TABLE 106.TERUMO: PRODUCT PORTFOLIO
TABLE 01.GLOBAL BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027 ($MILLION)
TABLE 02.POLYMERIC BIOABSORBABLE STENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.METALLIC BIOABSORBABLE STENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 05.BIOABSORBABLE STENTS MARKET FOR CORONARY ARTERY DISEASE, BY REGION, 2019–2027 ($MILLION)
TABLE 06.BIOABSORBABLE STENTS MARKET FOR PERIPHERAL ARTERY DISEASE, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL BIOABSORBABLE STENTS MARKET, BY END USE, 2019–2027 ($MILLION)
TABLE 08.BIOABSORBABLE STENTS MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.BIOABSORBABLE STENTS MARKET FOR CARDIAC CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 10.BIOABSORBABLE STENTS MARKET, BY REGION, 2019–2027, ($MILLION)
TABLE 11.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 12.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 15.U.S. BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 16.U.S. BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 17.U.S. BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 18.CANADA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 19.CANADA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 20.CANADA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 21.MEXICO BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 22.MEXICO BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 23.MEXICO BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 24.EUROPE BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 25.EUROPE BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 26.EUROPE BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 27.EUROPE BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 28.GERMANY BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 29.GERMANY BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 30.GERMANY BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 31.FRANCE BIOABSORBABLE STENTS MARKET, BY BIOMATERAIL, 2019–2027, ($MILLION)
TABLE 32.FRANCE BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 33.FRANCE BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 34.UK BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 35.UK BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 36.UK BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 37.ITALY BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 38.ITALY BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 39.ITALY BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 40.SPAIN BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 41.SPAIN BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 42.SPAIN BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 43.REST OF EUROPE BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 44.REST OF EUROPE BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 45.REST OF EUROPE BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 46.ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 47.ASIA PACIFIC BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 48.ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 49.ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 50.JAPAN BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 51.JAPAN BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 52.JAPAN BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 53.CHINA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 54.CHINA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 55.CHINA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 56.INDIA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 57.INDIA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 58.INDIA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 59.REST OF ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 60.REST OF ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 61.REST OF ASIA-PACIFIC BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 62.LAMEA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 63.LAMEA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 64.LAMEA BIOABSORBABLE STENTS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 65.LAMEA BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 66.BRAZIL BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 67.BRAZIL BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 68.BRAZIL BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 69.SAUDI ARABIA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 70.SAUDI ARABIA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 71.SAUDI ARABIA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 72.SOUTH AFRICA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 73.SOUTH AFRICA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 74.SOUTH AFRICA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 75.REST OF LAMEA BIOABSORBABLE STENTS MARKET, BY BIOMATERIAL, 2019–2027, ($MILLION)
TABLE 76.REST OF LAMEA BIOABSORBABLE STENTS MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 77.REST OF LAMEA BIOABSORBABLE STENTS MARKET, BY END USER, 2019-2027, ($MILLION)
TABLE 78.ART: COMPANY SNAPSHOT
TABLE 79.ART: OERATING SEGMENT
TABLE 80.ART: PRODUCT PORTFOLIO
TABLE 81.ARTERIUS: COMPANY SNAPSHOT
TABLE 82.ARTERIUS: OERATING SEGMENT
TABLE 83.ARTERIUS: PRODUCT PORTFOLIO
TABLE 84.B. BRAUN: COMPANY SNAPSHOT
TABLE 85.B. BRAUN: OERATING SEGMENT
TABLE 86.B. BRAUN: PRODUCT PORTFOLIO
TABLE 87.BIOTRONIK: COMPANY SNAPSHOT
TABLE 88.BIOTRONIK: OERATING SEGMENT
TABLE 89.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 90.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 91.BOSTON SCIENTIFIC: OERATING SEGMENT
TABLE 92.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 93.ELIXIR MEDICAL: COMPANY SNAPSHOT
TABLE 94.ELIXIR MEDICAL: OERATING SEGMENT
TABLE 95.ELIXIR MEDICAL: PRODUCT PORTFOLIO
TABLE 96.KYOTO MEDICAL PLANNING: COMPANY SNAPSHOT
TABLE 97.KYOTO MEDICAL PLANNING: OERATING SEGMENT
TABLE 98.KYOTO MEDICAL PLANNING: PRODUCT PORTFOLIO
TABLE 99.MICROPORT: COMPANY SNAPSHOT
TABLE 100.MICROPORT: OERATING SEGMENT
TABLE 101.MICROPORT: PRODUCT PORTFOLIO
TABLE 102.REVA MEDICAL: COMPANY SNAPSHOT
TABLE 103.REVA MEDICAL: PRODUCT PORTFOLIO
TABLE 104.TERUMO: COMPANY SNAPSHOT
TABLE 105.TERUMO: OERATING SEGMENT
TABLE 106.TERUMO: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL BIOABSORBABLE STENTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF POLYMERIC BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF METALLIC BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR CORONARY ARTERY DISEASE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR HOSPITAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.B. BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 21.B. BRAUN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 22.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 24.BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 25.MICROPORT: NET SALES, 2017–2019 ($MILLION)
FIGURE 26.MICROPORT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 27.MICROPORT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 28.TERUMO: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.TERUMO: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 30.TERUMO: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 01.GLOBAL BIOABSORBABLE STENTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF POLYMERIC BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF METALLIC BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR CORONARY ARTERY DISEASE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR HOSPITAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF BIOABSORBABLE STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.B. BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 21.B. BRAUN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 22.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 24.BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 25.MICROPORT: NET SALES, 2017–2019 ($MILLION)
FIGURE 26.MICROPORT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 27.MICROPORT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 28.TERUMO: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.TERUMO: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 30.TERUMO: REVENUE SHARE, BY REGION, 2020 (%)
